A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä

From ANA-screening to antigen-specificity: an EASI-survey on the daily practice in European countries.




TekijätDamoiseaux J, Agmon-Levin N, Van Blerk M, Chopyak V, Eriksson C, Heijnen I, Herold M, Høgåsen K, Musset L, Radice A, Rego de Sousa MJ, Viander M, Shoenfeld Y

Julkaisuvuosi2014

JournalClinical and Experimental Rheumatology

Tietokannassa oleva lehden nimiClinical and experimental rheumatology

Lehden akronyymiClin Exp Rheumatol

Vuosikerta32

Numero4

Aloitussivu539

Lopetussivu546

Sivujen määrä8

ISSN0392-856X


Tiivistelmä

OBJECTIVES\nOne of the main goals of the European Autoimmunity Standardisation Initiative (EASI) is the harmonisation of test-algorithms for autoantibodies related to systemic autoimmune rheumatic diseases (SARD).\nMETHODS\nA questionnaire was used to gather information on methodology, interpretation, and the algorithm for detection of anti-nuclear antibodies (ANA) in relation to their antigen-specificity. The questionnaire was sent to 1200 laboratories in 12 European countries.\nRESULTS\nThe response rate was 47.2%. The results reveal not only apparent differences between countries, but also within countries.\nCONCLUSIONS\nAwareness of these differences may as such already stimulate harmonisation, but the observed differences may also direct recommendations that may further contribute to achieving the EASI goal of harmonisation of autoimmune diagnostics for SARD.




Last updated on 2024-26-11 at 13:01